Iconic Labs Past Earnings Performance
Past criteria checks 0/6
Iconic Labs has been growing earnings at an average annual rate of 38.4%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been declining at an average rate of 111.5% per year.
Key information
38.4%
Earnings growth rate
66.4%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | -111.5% |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Iconic Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | 0 | -5 | 0 |
| 30 Sep 23 | 0 | 2 | -5 | 0 |
| 30 Jun 23 | 0 | 5 | -5 | 0 |
| 30 Jun 22 | 0 | -1 | 0 | 0 |
| 30 Jun 21 | 1 | -8 | 4 | 0 |
| 31 Dec 20 | 1 | -3 | 3 | 0 |
| 30 Sep 20 | 0 | -3 | 3 | 0 |
| 30 Jun 20 | 0 | -3 | 2 | 0 |
| 31 Dec 19 | 0 | -2 | 1 | 0 |
| 30 Sep 19 | 0 | -2 | 1 | 0 |
| 30 Jun 19 | 0 | -1 | 0 | 0 |
| 30 Jun 18 | 0 | -4 | 3 | 0 |
| 31 Mar 18 | 0 | -3 | 3 | 0 |
| 31 Dec 17 | 0 | -3 | 3 | 0 |
| 30 Sep 17 | 0 | -2 | 2 | 0 |
| 30 Jun 17 | 0 | -2 | 2 | 0 |
| 31 Mar 17 | 0 | -2 | 2 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
| 31 Dec 15 | 0 | 0 | 0 | 0 |
| 31 Dec 14 | 0 | 0 | 0 | 0 |
| 31 Dec 13 | 0 | 0 | 0 | 0 |
Quality Earnings: ICON is currently unprofitable.
Growing Profit Margin: ICON is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ICON is unprofitable, but has reduced losses over the past 5 years at a rate of 38.4% per year.
Accelerating Growth: Unable to compare ICON's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ICON is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2%).
Return on Equity
High ROE: ICON's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.